Drug Trial Radar · NCT06061471
To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Jan 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
454
Actual
Start
Sep 22, 2023
Primary completion
Dec 11, 2024
Study completion Dec 11, 2024
Sponsor
- Lead sponsor
- AkesoIndustry
- Sponsor type
- Industry
- First posted
- Sep 29, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and safety of AK111 in the treatment of subjects with moderate to severe plaque psoriasis.
Conditions
- Psoriasis
- Skin Diseases
Interventions
AK111Drug
AK111 regimen 1-subcutaneous injection,until week 24.
AK111Drug
AK111 regimen 2-subcutaneous injection,until week 24.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The percentage of subjects who achieved at least 75% reduction in Psoriasis Area Severity Index (PASI)score from baseline (PASI 75) and the percentage of subjects with sPGA 0/1 at week 16.Time frame: at week 16
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
Affiliated Hospital of Chengde Medical University
Chengde, Hebei, China
Nanyang First People's hospital national third class a hospital
Nanyang, Henan, China
Yichang central People's hospital
Yichang, Hubei, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
The affiliated hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Dermatology hospital of Jiangxi province
Nanchang, Jiangxi, China
Tianjin academy of traditional Chinese medicine affiliated hospital
Tianjin, Tianjin Municipality, China
Hangzhou First People's hospital
Hangzhou, Zhejiang, China
The first hospital of Jiaxing
Jiaxing, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.